Literature DB >> 9358774

Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis.

R S Yeung1, C D Katsetos, A Klein-Szanto.   

Abstract

Tuberous sclerosis (TSC) is an autosomal dominant syndrome that is linked to two genetic loci: TSC1 (9q34) and TSC2 (16p13). Brain manifestations such as cortical tubers and subependymal hamartoma/giant cell astrocytomas are major causes of TSC-related morbidity. In this study, we describe the central nervous system involvement in a unique rodent model of tuberous sclerosis. The Eker rat carries a spontaneous germline mutation of the TSC2 gene and is predisposed to multiple neoplasia. In a series of 45 adult Eker carriers (TSC2 +/-), three types of focal intracranial lesions were found, of which the subependymal and subcortical hamartomas were most prevalent (65%). There exist remarkable phenotypic similarities between the Eker rat and human subependymal lesions. Our study indicates that the predominant cellular phenotype of the subependymal hamartomas is astroglial and suggests that the neuronal contribution within these lesions is, in part, the result of pre-existing myelinated axons. The hamartomas did not show evidence of loss of the wild-type TSC2 allele; it remains to be determined whether TSC2 inactivation is necessary for their pathogenesis. This genetically-defined rodent model may be useful in elucidating the molecular and developmental basis of the subependymal giant cell astrocytoma in humans.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358774      PMCID: PMC1858083     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

1.  Mortality in the Mayo Clinic Tuberous Sclerosis Complex Study.

Authors:  C W Shepherd; M R Gomez
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

2.  Neuropsychiatric aspects of tuberous sclerosis.

Authors:  P Curatolo; R Cusmai; F Cortesi; C Chiron; I Jambaque; O Dulac
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

3.  A ras-related gene with transformation suppressor activity.

Authors:  H Kitayama; Y Sugimoto; T Matsuzaki; Y Ikawa; M Noda
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

4.  Calbindin D-28k and parvalbumin in the rat nervous system.

Authors:  M R Celio
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

5.  Cerebellar desmoplastic medulloblastomas. A further immunohistochemical characterization of the reticulin-free pale islands.

Authors:  C D Katsetos; M M Herman; A Frankfurter; P Gass; V P Collins; C C Walker; S Rosemberg; R O Barnard; L J Rubinstein
Journal:  Arch Pathol Lab Med       Date:  1989-09       Impact factor: 5.534

6.  Unexpected immunoreactivities of intermediate filament antibodies in human brain and brain tumors.

Authors:  F E Franke; W Schachenmayr; M Osborn; M Altmannsberger
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

7.  Subependymal giant cell astrocytoma. Significance and possible cytogenetic implications of an immunohistochemical study.

Authors:  J M Bonnin; L J Rubinstein; S C Papasozomenos; P J Marangos
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

8.  Subependymal giant-cell astrocytoma. Case report with ultrastructural study.

Authors:  A A Sima; D M Robertson
Journal:  J Neurosurg       Date:  1979-02       Impact factor: 5.115

9.  Tuberous sclerosis in the premature infant: a report of a case with immunohistochemistry on the CNS.

Authors:  T M Chou; S M Chou
Journal:  Clin Neuropathol       Date:  1989 Jan-Feb       Impact factor: 1.368

10.  Central nervous system pathology of tuberous sclerosis in children.

Authors:  B L Bender; E J Yunis
Journal:  Ultrastruct Pathol       Date:  1980 Jul-Sep       Impact factor: 1.094

View more
  21 in total

1.  Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development.

Authors:  G Rennebeck; E V Kleymenova; R Anderson; R S Yeung; K Artzt; C L Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 2.  The neurobiology of the tuberous sclerosis complex.

Authors:  Leah Marcotte; Peter B Crino
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 3.  The tuberous sclerosis complex.

Authors:  Ksenia A Orlova; Peter B Crino
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

4.  Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background.

Authors:  H Onda; A Lueck; P W Marks; H B Warren; D J Kwiatkowski
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

Review 5.  Animal models of lymphangioleiomyomatosis (LAM) and tuberous sclerosis complex (TSC).

Authors:  David J Kwiatkowski
Journal:  Lymphat Res Biol       Date:  2010-03       Impact factor: 2.589

6.  The FHIT gene product is highly expressed in the cytoplasm of renal tubular epithelium and is down-regulated in kidney cancers.

Authors:  G H Xiao; F Jin; A J Klein-Szanto; T L Goodrow; M W Linehan; R S Yeung
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

7.  Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors.

Authors:  E P Henske; L L Wessner; J Golden; B W Scheithauer; A O Vortmeyer; Z Zhuang; A J Klein-Szanto; D J Kwiatkowski; R S Yeung
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

8.  Animal models of focal cortical dysplasia and tuberous sclerosis complex: recent progress toward clinical applications.

Authors:  Michael Wong
Journal:  Epilepsia       Date:  2009-10       Impact factor: 5.864

Review 9.  Growth controls connect: interactions between c-myc and the tuberous sclerosis complex-mTOR pathway.

Authors:  Emmett V Schmidt; Michael J Ravitz; Li Chen; Mary Lynch
Journal:  Cell Cycle       Date:  2009-05-18       Impact factor: 4.534

10.  Genetics and molecular biology of tuberous sclerosis complex.

Authors:  Valerio Napolioni; Paolo Curatolo
Journal:  Curr Genomics       Date:  2008-11       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.